[Federal Register Volume 83, Number 171 (Tuesday, September 4, 2018)]
[Notices]
[Page 44892]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-19051]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-6: NCI Clinical and Translational R21 & Omnibus R03.
    Date: October 4, 2018.
    Time: 7:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975, 
<a href="/cdn-cgi/l/email-protection#fd9e95889b9c939898bd909c9491d3939495d39a928b"><span class="__cf_email__" data-cfemail="9dfef5e8fbfcf3f8f8ddf0fcf4f1b3f3f4f5b3faf2eb">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-9: NCI Clinical and Translational R21 and Omnibus R03.
    Date: October 23, 2018.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371, 
<a href="/cdn-cgi/l/email-protection#573332343b22323d173a363e3b79393e3f79303821"><span class="__cf_email__" data-cfemail="0e6a6b6d627b6b644e636f67622060676620696178">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee I--Transition to Independence.
    Date: October 24-25, 2018.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The William F. Bolger Center, 9600 Newbridge Drive, 
Potomac, MD 20854.
    Contact Person: Delia Tang, MD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W602, Bethesda, MD 20892-9750, 240-276-6456, <a href="/cdn-cgi/l/email-protection#aadecbc4cdceeac7cbc3c684c4c3c284cdc5dc"><span class="__cf_email__" data-cfemail="3b4f5a555c5f7b565a525715555253155c544d">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-8: NCI Clinical and Translational R21 and Omnibus R03.
    Date: November 1-2, 2018.
    Time: 6:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Reed A. Graves, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W106, Bethesda, MD 20892-9750, 240-276-6384, 
<a href="/cdn-cgi/l/email-protection#90f7e2f1e6f5e3e2d0fdf1f9fcbefef9f8bef7ffe6"><span class="__cf_email__" data-cfemail="1f786d7e697a6c6d5f727e76733171767731787069">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; HIV/AIDS and the Tumor Niche.
    Date: November 13, 2018.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W618, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W618, Bethesda, MD 20892-9750, 240-276-6611, <a href="/cdn-cgi/l/email-protection#e588908e80968dcb8e90888497d6a58b8c8dcb828a93"><span class="__cf_email__" data-cfemail="c4a9b1afa1b7aceaafb1a9a5b6f784aaadaceaa3abb2">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 28, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-19051 Filed 8-31-18; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>